Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study led by geneticist Erwin Wagner has uncovered new insights into the disease mechanisms of OS, paving the way for potential new diagnostic and treatment strategies…
Read More
Study identifies 10 risk factors for Alzheimer’s disease
Scientists led by a team in China have identified 10 risk factors for Alzheimer’s disease. The 10 factors are diabetes, poor BMI, reduced education, high blood pressure in midlife, low blood pressure, head trauma, high levels of homocysteine, less cognitive…
Read More
Researchers identify possible drug target for prostate cancer
Researchers from Boston University School of Medicine (BUSM) have discovered that the protein BRD4 could be an important new target to prevent castration-resistant prostate cancer metastases. Castration-resistant prostate cancer is a highly aggressive form of prostate cancer that often leads…
Read More
Discovery of new immune targets inside flu virus offers hope for universal vaccine
New markers hidden inside the influenza virus have been discovered by scientists at Cardiff University. The researchers from the School of Medicine worked with an international team of experts—including collaborators in Moscow, Russia and Melbourne, Australia—to look at how people’s…
Read More
Ticagrelor-aspirin beneficial for mild-to-moderate stroke, TIA
(HealthDay)—Ticagrelor-aspirin is associated with a reduced risk for the composite of stroke or death within 30 days of mild-to-moderate acute noncardioembolic ischemic stroke or transient ischemic attack (TIA), according to a study published in the July 16 issue of the…
Read More
Scientists ID gene responsible for deadly glioblastoma
Scientists have identified an oncogene (a cancer-causing gene) responsible for glioblastoma, the deadliest brain tumor. The discovery offers a promising new treatment target for a cancer that is always fatal. The researchers say the oncogene is essential to the survival…
Read More
Computer guided drug delivery developed for brain disorders
While we are starting to get a handle on drugs and therapeutics that might to help alleviate brain disorders, efficient delivery remains a roadblock to tackling these devastating diseases. New research from the Graybiel, Cima, and Langer labs at MIT…
Read More
New treatment for rare blood cancer approved for NHS use in England
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin to treat some adults with a rare type of fast-growing lymphoma. Clinical trial data suggests that combining the targeted treatment with chemotherapy could give people…
Read More
This bacterium, the Risk for heart lowers diseases – Naturopathy naturopathy specialist portal
Effect of Eubacterium limosum on health? A special bacterium in the gut seems to reduce the risk for heart disease. The bacterium reduces the production of a substance that is related to the development of clogged arteries in combination. In…
Read More
Nemolizumab beats placebo for reduction of pruritus in eczema
(HealthDay)—For patients with atopic dermatitis and moderate-to-severe pruritus, nemolizumab results in a greater reduction in pruritus than placebo, according to a study published in the July 9 issue of the New England Journal of Medicine. Kenji Kabashima, M.D., Ph.D., from…
Read More